Insider Transactions in Q3 2022 at Volitionrx LTD (VNRX)
Insider Transaction List (Q3 2022)
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Sep 19
2022
|
Jacob Vincent Micallef Chief Scientific Officer |
BUY
Open market or private purchase
|
Indirect |
13,000
+27.08%
|
$13,000
$1.7 P/Share
|
|
Aug 30
2022
|
Cameron John Reynolds President and CEO |
BUY
Open market or private purchase
|
Direct |
3,500
+0.29%
|
$3,500
$1.61 P/Share
|
|
Aug 26
2022
|
Jacob Vincent Micallef Chief Scientific Officer |
BUY
Open market or private purchase
|
Direct |
29,000
+16.27%
|
$29,000
$1.74 P/Share
|
|
Aug 23
2022
|
Salvatore Thomas Butera CEO, Volition Veterinary |
BUY
Open market or private purchase
|
Direct |
5,000
+2.94%
|
$5,000
$1.6 P/Share
|
|
Aug 22
2022
|
Salvatore Thomas Butera CEO, Volition Veterinary |
BUY
Open market or private purchase
|
Direct |
5,000
+3.03%
|
$5,000
$1.64 P/Share
|
|
Aug 15
2022
|
Mickie Henshall |
BUY
Grant, award, or other acquisition
|
Direct |
15,000
+50.0%
|
-
|
|
Aug 03
2022
|
Jason Bradley Md Terrell Chief Medical Officer |
SELL
Payment of exercise price or tax liability
|
Indirect |
404
-14.8%
|
$404
$1.97 P/Share
|
|
Aug 03
2022
|
Jason Bradley Md Terrell Chief Medical Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
4,279
-12.18%
|
$4,279
$1.97 P/Share
|
|
Aug 03
2022
|
Jacob Vincent Micallef Chief Scientific Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
4,825
-3.86%
|
$4,825
$1.97 P/Share
|
|
Aug 03
2022
|
Gael Forterre Chief Commercial Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
3,598
-5.22%
|
$3,598
$1.97 P/Share
|
|
Aug 03
2022
|
Martin Charles Faulkes Executive Director |
SELL
Payment of exercise price or tax liability
|
Direct |
4,825
-0.32%
|
$4,825
$1.97 P/Share
|
|
Aug 02
2022
|
Guy Archibald Innes |
BUY
Open market or private purchase
|
Indirect |
300,000
+50.0%
|
$600,000
$2.0 P/Share
|
|
Aug 02
2022
|
Guy Archibald Innes |
BUY
Open market or private purchase
|
Direct |
12,500
+0.79%
|
$25,000
$2.0 P/Share
|